SUBSCRIBE
SUBSCRIBE
News   Business

Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceuticals, Inc. Dumps Arena Pharmaceuticals, Inc. Diabetes Drug, APD597

November 5, 2010 | 
1 min read
Bloomberg -- Johnson & Johnson’s Ortho-McNeil- Janssen Pharmaceuticals Inc. is ending its collaboration on APD597 with Arena Pharmaceuticals Inc. on Dec. 28.
Alliances
Johnson & Johnson Family of Companies
MORE ON THIS TOPIC
Business people shaking hand in China.
Collaboration
Crescent, Kelun-Biotech Swap Therapies in ADC-Bispecific Deal Worth Up To $1.25B
December 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration of a syringe and medicine bottle with some broken glass
Manufacturing
Biotechs Secure Alternative Fill/Finish Capacity Amid Scrutiny of Novo Site
December 2, 2025
 · 
6 min read
 · 
Nick Paul Taylor
A piggy bank crammed with $100 bills on a background of American cash
Series B
Novartis-Backed Protego Eyes Pivotal Amyloidosis Study With $130M Series B
December 1, 2025
 · 
1 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Valneva Terminates 30 Amid Site Closure
December 1, 2025
 · 
92 min read
 · 
BioSpace Editorial Staff